JPH05115464A - Blood taking tube under reduced pressure - Google Patents

Blood taking tube under reduced pressure

Info

Publication number
JPH05115464A
JPH05115464A JP3307012A JP30701291A JPH05115464A JP H05115464 A JPH05115464 A JP H05115464A JP 3307012 A JP3307012 A JP 3307012A JP 30701291 A JP30701291 A JP 30701291A JP H05115464 A JPH05115464 A JP H05115464A
Authority
JP
Japan
Prior art keywords
tube
blood
reduced pressure
present
blood collection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3307012A
Other languages
Japanese (ja)
Inventor
Hiroshi Yoshioka
宏 吉岡
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nissho Corp
Original Assignee
Nissho Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissho Corp filed Critical Nissho Corp
Priority to JP3307012A priority Critical patent/JPH05115464A/en
Publication of JPH05115464A publication Critical patent/JPH05115464A/en
Pending legal-status Critical Current

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Abstract

PURPOSE:To provide the subject tube which is less changed in a reduced pressure state with lapse of time before use and has an excellent property to accelerate blood clotting. CONSTITUTION:The blank material of the blind tubular body having a sealing member of the objective tube consists of 99 to 92wt.% polyester essentially consisting of polyethylene terephthalate and 1 to 8wt.% xylene group-contg. polyamide and, further, contains 1 to 100ppm transition metal. A silicon material and a blood clotting accelerator exist in a dispersed state in the inside wall of this tube.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、減圧採血管に関するも
のである。更に詳しくは使用前の減圧状態の経時による
変化が少なく、かつ血液凝固促進性に優れた減圧採血管
に関するものである。
FIELD OF THE INVENTION The present invention relates to a reduced pressure blood collection tube. More specifically, the present invention relates to a reduced pressure blood collection tube which has little change in decompressed state before use with time and is excellent in blood coagulation accelerating property.

【0002】[0002]

【従来の技術】減圧採血管は生化学検査・血清学検査、
血液学検査、血糖測定、血液凝固検査、血沈検査、細菌
学検査等に用いられ、開口部を有する有底管にゴム栓を
付けたものからなる。この有底管の内部は使用時に減圧
状態に保持されていることが必要で、その減圧の度合い
は、血液量(1〜20ml)を必要なだけ採血できるよ
うにそれ相当の減圧状態に保持されている。
2. Description of the Related Art Vacuum blood collection tubes are used for biochemical and serological tests,
It is used for hematology test, blood glucose measurement, blood coagulation test, blood sedimentation test, bacteriology test, etc., and consists of a bottomed tube having an opening with a rubber stopper. It is necessary that the inside of this bottomed tube is kept in a depressurized state at the time of use, and the degree of depressurization is kept in a depressurized state corresponding to it so that the blood volume (1 to 20 ml) can be collected as much as necessary. ing.

【0003】従来から上記有底管の素材はガラスであっ
たが、ガラスは破損しやすいため、最近では合成樹脂に
代替されつつある。減圧採血管用合成樹脂としては、ポ
リエステル、ポリエチレン、ポリプロピレン等から選択
される。
Conventionally, the material for the bottomed tube has been glass, but since glass is easily broken, it is being replaced by synthetic resin recently. The synthetic resin for the vacuum blood collection tube is selected from polyester, polyethylene, polypropylene and the like.

【0004】合成樹脂管はこのまま減圧採血管に用いら
れると血液の凝固が遅く、遠心分離法で血清と血球に分
離する場合には長時間を要するという問題点がある。採
血から血液の凝固までの時間が長くなると緊急の検査に
おいて不都合であるばかりか、血清中にフイブリンが生
成しやすくなり、よい血液サンプルが採れない。このた
め合成樹脂製減圧採血管を用いて遠心分離法で血清と血
球に分離する場合には血液凝固促進剤を添加する必要が
ある。
If the synthetic resin tube is used as it is for a vacuum blood collection tube, coagulation of blood is slow, and it takes a long time to separate serum and blood cells by a centrifugation method. If the time from blood collection to blood coagulation is long, it is not convenient for an emergency test, and fibrin is easily produced in serum, so that a good blood sample cannot be collected. For this reason, it is necessary to add a blood coagulation promoter when separating blood serum and blood cells by centrifugation using a synthetic resin vacuum blood collection tube.

【0005】一方、血液凝固促進剤のみでは管壁に血液
が血餅となって付着しやすいので、管壁に血餅を付着さ
せない物質、例えば親水性シリコンを用いる必要があ
る。
On the other hand, since blood tends to adhere to the tube wall as blood clots only with the blood coagulation promoter, it is necessary to use a substance that does not adhere blood clots to the tube wall, such as hydrophilic silicone.

【0006】[0006]

【発明が解決しようとする課題】合成樹脂製減圧採血管
はガラス製減圧採血管よりもガスバリアー性において見
劣りする。そのため保管中は減圧採血管を真空包装する
か、包装内部に特定のガスを含有させるとか、包装材料
の検討等がなされてきた。
The synthetic resin vacuum blood collection tube is inferior to the glass vacuum blood collection tube in gas barrier property. For this reason, studies have been made on packaging materials such as vacuum packaging of vacuum blood collection tubes during storage, or inclusion of a specific gas inside the packaging.

【0007】また、血液凝固促進剤と管壁に血餅を付着
させない物質の両者は、凝集に関して相反する効果を持
つ物質であるから、両者をうまく存在させるための制御
が難しい。
Further, since both the blood coagulation promoter and the substance that does not allow blood clots to adhere to the tube wall are substances having contradictory effects on agglutination, it is difficult to control them so that they exist well.

【0008】本発明は、ガスバリアー性において優れ、
かつ血液凝固促進性に優れた合成樹脂製減圧採血管を提
供することが目的であり、本発明によれば、採血前の減
圧採血管内部の減圧状態が長時間にわたり保持され、血
液凝固促進性に優れ、血液凝固促進剤と管壁に血餅を付
着させない物質の両者をうまく管壁に存在させることが
できる。
The present invention has excellent gas barrier properties,
And it is an object to provide a synthetic resin reduced-pressure blood collection tube excellent in blood coagulation accelerating property, and according to the present invention, the reduced pressure state inside the reduced pressure blood collection tube before blood collection is maintained for a long time, and blood coagulation accelerating property Both the blood coagulation promoter and the substance that does not allow blood clots to adhere to the tube wall can be successfully present on the tube wall.

【0009】[0009]

【課題を解決するための手段】本発明は,封止部材及び
有底管体からなり、この有底管体の素材が、ポリエチレ
ンテレフタレート又はポリエチレンテレフタレートを主
成分とするポリエステル99〜92重量%と、キシリレ
ン基含有ポリアミド1〜8重量%の組成を有し、更に遷
移金属を1〜100ppm含有する減圧採血管であっ
て、管内壁にシリコン系物質と血液凝固促進剤が分散さ
れた状態で存在することを特徴とする減圧採血管を要旨
とする。
The present invention comprises a sealing member and a bottomed tubular body, and the material of the bottomed tubular body is polyethylene terephthalate or a polyester containing polyethylene terephthalate as a main component in an amount of 99 to 92% by weight. A vacuum blood collection tube having a composition of 1 to 8% by weight of a xylylene group-containing polyamide and further containing 1 to 100 ppm of a transition metal, wherein a silicon-based substance and a blood coagulation promoter are dispersed in the inner wall of the tube. The gist is a reduced-pressure blood collection tube characterized by:

【0010】本発明において封止部材とは減圧採血管に
用いられるものを言う。例えば、脱着可能な弾性を有す
るゴム栓やガスバリアー部材とシール部材からなる封止
部材を言う。
In the present invention, the sealing member means a member used for a reduced pressure blood collection tube. For example, the term refers to a detachable elastic rubber plug or a sealing member including a gas barrier member and a sealing member.

【0011】本発明においてポリエチレンテレフタレー
トとは汎用のポリエステルでエチレングリコールとテレ
フタール酸又はそのエステル(特にジメチルテレフタレ
ート)との反応によって得られるものである。しかし、
エチレンテレフタレートからなる反復単位が60%以上
のものも含まれる。共重合成分としては、イソフタール
酸・ナフタレンジカルボン酸・p−オキシ安息香酸誘導
体;ブタンジオール等がある。
In the present invention, polyethylene terephthalate is a general-purpose polyester obtained by reacting ethylene glycol with terephthalic acid or its ester (especially dimethyl terephthalate). But,
It also includes ethylene terephthalate having a repeating unit content of 60% or more. Examples of the copolymerization component include isophthalic acid / naphthalenedicarboxylic acid / p-oxybenzoic acid derivative; butanediol.

【0012】上記ポリエステルの重合体の分子量は固有
粘度〔η〕にして0.6〜0.9であれば、成形におい
て問題なく、満足できる本発明用の有底管体が得られ
る。
If the molecular weight of the polyester polymer is an intrinsic viscosity [η] of 0.6 to 0.9, a satisfactory bottomed tubular body for use in the present invention can be obtained without problems in molding.

【0013】本発明においてキシリレン基含有ポリアミ
ドは、例えば、m−キシリレンジアミンとアジピン酸の
縮合反応からなるポリm−キシリレンアジパミドが構成
単位の70%以上であり、共重合成分としては、p−キ
シリレンアジパミド、ヘキサメチレンジアミン;アミノ
カプロン酸、セバチン酸などがある。
In the present invention, the xylylene group-containing polyamide contains, for example, poly-m-xylylene adipamide, which is formed by the condensation reaction of m-xylylenediamine and adipic acid, in an amount of 70% or more of the constitutional unit, and as a copolymerization component. , P-xylylene adipamide, hexamethylene diamine; aminocaproic acid, sebacic acid and the like.

【0014】本発明において遷移金属は塩の形で用い、
酢酸コバルト、ナフテン酸コバルト、ステアリン酸コバ
ルト、ニツケルアセチルアセテート、塩化ニツケル、塩
化ロジウムなどがある。
In the present invention, the transition metal is used in the form of a salt,
Examples include cobalt acetate, cobalt naphthenate, cobalt stearate, nickel acetyl acetate, nickel chloride, and rhodium chloride.

【0015】本発明において有底管体の素材がポリエチ
レンテレフタレートとキシリレン基含有ポリアミド、遷
移金属の塩からなる混合物であるが、この混合は成形工
程における仕込時又はその時までに原料を混合しておけ
ばよい。
In the present invention, the material of the bottomed tubular body is a mixture of polyethylene terephthalate, xylylene group-containing polyamide, and a salt of a transition metal. This mixing may be carried out by mixing the raw materials at the time of charging in the molding step or by that time. Good.

【0016】キシリレン基含有ポリアミドを混合して成
形することにより、製品に黄味が生じることがある。組
成をうまくバランスさせることにより、この黄味を消す
ことができる。この黄味は、青色又は紫色系統の顔料を
約1%含有するマスターチツプをつくり、このマスター
チツプを重量にしてキシリレン基含有ポリアミドと同程
度に添加して消すこともできる。
When a xylylene group-containing polyamide is mixed and molded, the product may have a yellowish tint. A good balance of composition can eliminate this yellowing. This yellowish tint can be eliminated by preparing a master chip containing about 1% of a blue or purple pigment and adding the master chip by weight to the same extent as the xylylene group-containing polyamide.

【0017】本発明は、有底管体と封止部材からなる減
圧採血管であって、上記のように有底管体の素材がポリ
エチレンテレフタレート又はポリエチレンテレフタレー
トを主成分とするポリエステルとキシリレン基含有ポリ
アミドからなり、更に遷移金属を含有することを第1の
特徴とし、管内壁にシリコン系物質と血液凝固促進剤が
分散された状態で存在することを第2の特徴とする。
The present invention is a reduced pressure blood collection tube comprising a bottomed tube and a sealing member, wherein the material of the bottomed tube contains polyethylene terephthalate or a polyester containing polyethylene terephthalate as a main component and a xylylene group. The first characteristic is that it is made of polyamide and further contains a transition metal, and the second characteristic is that the silicon-based substance and the blood coagulation promoter are present in a dispersed state on the inner wall of the tube.

【0018】血液を付着しにくい物質としては親水性シ
リコンを用いる。本発明では親水性シリコンと血液凝固
促進剤が分散状態で管内壁に存在するようになる。
Hydrophilic silicone is used as a substance to which blood is unlikely to adhere. In the present invention, the hydrophilic silicon and the blood coagulation promoter are present on the inner wall of the tube in a dispersed state.

【0019】このとき親水性シリコンの親水性度を選ぶ
ことにより、管内壁面に親水性シリコン層を形成するこ
とができる。
At this time, a hydrophilic silicon layer can be formed on the inner wall surface of the tube by selecting the hydrophilicity of the hydrophilic silicon.

【0020】一般に血液凝固促進剤は溶媒に不溶なので
コーテイング時は懸濁状態で存在するが、これに水溶性
ポリマーを添加した方が血液凝固促進剤を安定した状態
で存在させるので好ましい。
Generally, a blood coagulation promoter is insoluble in a solvent and therefore exists in a suspended state during coating. However, it is preferable to add a water-soluble polymer to this so that the blood coagulation promoter can exist in a stable state.

【0021】また、コーテイング時の血液凝固促進剤混
合液を安定状態にするために、例えばシリコンを加えて
もよい。この場合のシリコンは親水性ではあるが、水に
は殆ど溶けないシリコンオイルが用いられる。
Further, for example, silicon may be added in order to stabilize the blood coagulation promoter mixed liquid during coating. Silicone in this case is hydrophilic, but silicone oil which is almost insoluble in water is used.

【0022】本発明において血液凝固促進剤液に添加す
る水溶性ポリマーとしてはポリビニルアルコール、ポリ
ビニルピロリドン、ポリエチレングリコール、ポリアク
リルアミド、ポリアクリル酸、メチルセルロース、カル
ボキシメチルセルロース、ヒドロキシエチルセルロー
ス、澱粉、カゼイン等が用いられる。
As the water-soluble polymer to be added to the blood coagulation promoter solution in the present invention, polyvinyl alcohol, polyvinylpyrrolidone, polyethylene glycol, polyacrylamide, polyacrylic acid, methyl cellulose, carboxymethyl cellulose, hydroxyethyl cellulose, starch, casein and the like are used. ..

【0023】本発明において管壁に分散させる親水性シ
リコンとしては、親水性度が高く水溶性のものであり、
ポリエーテルポリジメチルシロキサン共重合体、フツ素
変性シリコンオイル、アルコール変性シリコンオイルの
他、カルボキシル基、アミノ基、メチロール基等の親水
性基で変性したシリコンが用いられる。
In the present invention, the hydrophilic silicon dispersed in the tube wall is highly hydrophilic and water-soluble.
In addition to the polyether polydimethylsiloxane copolymer, fluorine-modified silicone oil, alcohol-modified silicone oil, silicone modified with a hydrophilic group such as carboxyl group, amino group and methylol group is used.

【0024】本発明において、血液凝固促進剤としては
珪砂、結晶シリカ微粉末、珪藻土、ガラス微粉末、カオ
リン、ベントナイト、セライト、炭酸カルシウム微粉
末、酸化チタン微粉末等が用いられる。
In the present invention, as the blood coagulation promoter, silica sand, crystalline silica fine powder, diatomaceous earth, glass fine powder, kaolin, bentonite, celite, calcium carbonate fine powder, titanium oxide fine powder and the like are used.

【0025】[0025]

【作用】本発明において、汎用のポリエステルにキシリ
レン基含有ポリアミドを混合し、遷移金属塩を含有させ
るのは、ガスバリアー性の優れた有底管体を得るととも
に、キシリレン基含有ポリアミドで酸素を吸収させるた
めであり、遷移金属塩がこの挙動を促進させる触媒にな
ると考えられている。
In the present invention, the general-purpose polyester is mixed with the xylylene group-containing polyamide to contain the transition metal salt in order to obtain a bottomed tubular body having an excellent gas barrier property and to absorb oxygen with the xylylene group-containing polyamide. It is considered that the transition metal salt serves as a catalyst for promoting this behavior.

【0026】ガスバリアー性において優れた本発明の合
成樹脂製減圧採血管はこのように酸素を吸収させて、使
用前の減圧採血管内部の減圧状態が在庫中から採血に至
る長期間にわたって保持されることになる。
The synthetic resin vacuum blood collection tube of the present invention, which is excellent in gas barrier properties, absorbs oxygen in this manner, and the reduced pressure inside the vacuum blood collection tube before use is maintained for a long period of time from inventory to blood collection. Will be.

【0027】本発明において上記混合物がポリエチレン
テレフタレート99〜92重量%とキシリレン基含有ポ
リアミド1〜8重量%の混合比にする必要がある。キシ
リレン基含有ポリアミドがこの限定値よりも多くなる
と、透明性が悪くなり、かつ、管体の原料費が高価なも
のになる。またこの限定値よりも少なくなると管体の酸
素吸収性が劣ることになる。
In the present invention, the mixture should have a mixing ratio of 99 to 92% by weight of polyethylene terephthalate and 1 to 8% by weight of xylylene group-containing polyamide. When the amount of the xylylene group-containing polyamide is more than this limit value, the transparency becomes poor and the raw material cost of the tubular body becomes expensive. On the other hand, if it is less than this limit value, the oxygen absorbability of the tubular body is deteriorated.

【0028】本発明において遷移金属塩を有底管体の素
材ポリマーに対して1〜100ppm含有させる必要が
ある。遷移金属塩がこの限定値よりも多くなると、管体
が着色し透明性が悪くなり、かつ原料費が高価になる。
またこの限定値よりも少なくなると、酸素吸収性を促進
する触媒作用の働きが劣ることになる。
In the present invention, the transition metal salt needs to be contained in an amount of 1 to 100 ppm with respect to the material polymer of the bottomed tubular body. If the amount of the transition metal salt is more than this limit value, the tube is colored, the transparency is deteriorated, and the raw material cost is increased.
On the other hand, when the amount is less than the limit value, the function of the catalytic action for promoting the oxygen absorption property is deteriorated.

【0029】本発明における有底管体用ポリマーは、採
血管に対して悪影響を与えない添加剤ならば、もちろん
それを含有してもよい。例えば、酸化防止剤、紫外線遮
断剤、押しだし助剤その他物性改善用添加剤などであ
る。
The polymer for bottomed tubing in the present invention may of course contain an additive that does not adversely affect the blood collection tube. Examples thereof include antioxidants, ultraviolet blocking agents, extrusion aids and other additives for improving physical properties.

【0030】本発明において、管内壁は親水性シリコン
で被われるので、血液が管壁に付着しにくい。血液凝固
促進剤は管壁に分散された状態で存在するので、血餅を
管壁に付着させない。血液凝固促進剤は分散された状態
ではあるが、大部分が血液側に存在しているので、血液
とより多く接触させることができ、凝固を早く完了させ
ることができる。
In the present invention, the inner wall of the tube is covered with hydrophilic silicon, so that blood is unlikely to adhere to the tube wall. Since the blood coagulation promoter exists in a state of being dispersed in the tube wall, the blood clot does not adhere to the tube wall. Although the blood coagulation promoter is in a dispersed state, most of it is present on the blood side, so that it can be brought into more contact with blood and coagulation can be completed quickly.

【0031】[0031]

【実施例】以下、本発明を実施例により具体的に説明す
る。表1に示す組成の材料を用いて、一端が閉塞し、か
つ他端が開口した肉厚1.3mm、内径12.8mmで
容量が5mlの有底管体をつくり、管内を−450mm
Hgの減圧状態としてブチルゴム製のゴム栓で密栓した
採血管を得た。
EXAMPLES The present invention will be specifically described below with reference to examples. Using the materials having the compositions shown in Table 1, a bottomed tubular body having a wall thickness of 1.3 mm, an inner diameter of 12.8 mm, and a volume of 5 ml with one end closed and the other end open was prepared, and the inside of the tube was -450 mm.
A blood collection tube was obtained which was hermetically sealed with a rubber stopper made of butyl rubber under a reduced pressure of Hg.

【0032】このようにして得られた減圧採血管を実施
例・比較例とも各10本ずつを供して50℃で保存した
後、2週間ごとに真空度保持率を測定した。その結果を
表1に示した。
The vacuum blood collection tubes thus obtained were provided with 10 tubes for each of Examples and Comparative Examples and stored at 50 ° C., after which the degree of vacuum retention was measured every two weeks. The results are shown in Table 1.

【0033】次いで、実施例2の組成からなる管の内壁
に、シリコンオイル0.5、セライト微粉末(粒径5〜
20μm)1.0、ポリビニルピロリドン1.0重量
%、イソプロピルアルコール液を管内壁に噴霧し、40
℃で乾燥した。
Then, on the inner wall of the tube having the composition of Example 2, 0.5 of silicon oil and fine powder of celite (particle size 5 to 5) were used.
20 μm) 1.0, polyvinylpyrrolidone 1.0% by weight, isopropyl alcohol liquid is sprayed on the inner wall of the tube,
It was dried at ° C.

【0034】シリコンオイルとしては、親水性度の異な
るポリエーテル変性シリコン(東芝シリコン製)を用
い、TSF4440(凝固点5℃、1%水溶液曇点67
℃)及びTSF4445(凝固点−5℃、1%水溶液曇
点なし)、TSF4452(凝固点−20℃以下、1%
水溶液曇点31℃)の3種類を用いた。
As the silicone oil, polyether-modified silicone (made by Toshiba Silicon) having different hydrophilicity was used, and TSF4440 (freezing point 5 ° C., 1% aqueous solution cloud point 67) was used.
C.) and TSF4445 (freezing point −5 ° C., 1% aqueous solution without cloud point), TSF4452 (freezing point −20 ° C. or lower, 1%
Three types of aqueous solution cloud point 31 ° C.) were used.

【0035】[0035]

【表1】 [Table 1]

【0036】この管を−450mmHgで真空打栓した
もの、各10本に、採血直後のウサギ心臓からの血液を
真空採血で採血し、転倒混和させた後、30秒ごとに傾
斜して凝固までの時間を測定した。その後45分放置
し、1300G、10分の条件で遠心分離を行い、血液
の状態を観察した。
This tube was vacuum-stopped at -450 mmHg, and 10 tubes each were collected by vacuum sampling blood from the rabbit heart immediately after blood sampling, mixed by inversion, and then inclined every 30 seconds until coagulation. Was measured. After that, it was left for 45 minutes, centrifuged at 1300 G for 10 minutes, and the state of blood was observed.

【0037】その結果を表2に示した。凝固時間は8〜
12分で、管壁への血餅付着は少なく、溶血やフイブリ
ン生成を起こした管は一本もなかった。
The results are shown in Table 2. Coagulation time is 8 ~
At 12 minutes, there was little blood clot adhesion to the tube wall, and no tube caused hemolysis or fibrin formation.

【0038】[0038]

【表2】 [Table 2]

【0039】[0039]

【発明の効果】本発明は、(1)有底管体の素材がポリ
エチレンテレフタレート又はポリエチレンテレフタレー
トを主成分とするポリエステルとキシリレン基含有ポリ
アミドからなり、更に遷移金属を含有されているので、
使用前の減圧状態の経時による変化が少ない減圧採血管
を提供でき、また、(2)管内壁にシリコン系物質と血
液凝固促進剤が分散された状態で存在するので、血液凝
固促進性に優れた減圧採血管を提供できる。
EFFECTS OF THE INVENTION According to the present invention, since (1) the material of the bottomed tubular body is polyethylene terephthalate or a polyester containing polyethylene terephthalate as a main component and a xylylene group-containing polyamide, a transition metal is further contained.
It is possible to provide a reduced-pressure blood collection tube with little change in the reduced-pressure state before use over time, and (2) because the silicon-based substance and the blood coagulation promoter are dispersed in the inner wall of the tube, it has excellent blood coagulation accelerating properties. A reduced pressure blood collection tube can be provided.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 封止部材及び有底管体からなり、この有
底管体の素材が、ポリエチレンテレフタレート又はポリ
エチレンテレフタレートを主成分とするポリエステル9
9〜92重量%と、キシリレン基含有ポリアミド1〜8
重量%の組成を有し、更に遷移金属を1〜100ppm
含有する減圧採血管であって、管内壁にシリコン系物質
と血液凝固促進剤が分散された状態で存在することを特
徴とする減圧採血管。
1. A sealing member and a bottomed tubular body, wherein the bottomed tubular body is made of polyethylene terephthalate or polyester 9 containing polyethylene terephthalate as a main component.
9 to 92 wt% and xylylene group-containing polyamide 1 to 8
It has a composition of wt% and further contains 1 to 100 ppm of transition metal.
A reduced-pressure blood collection tube containing, wherein a silicon-based substance and a blood coagulation promoter are present in a dispersed state on the inner wall of the tube.
JP3307012A 1991-10-25 1991-10-25 Blood taking tube under reduced pressure Pending JPH05115464A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP3307012A JPH05115464A (en) 1991-10-25 1991-10-25 Blood taking tube under reduced pressure

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3307012A JPH05115464A (en) 1991-10-25 1991-10-25 Blood taking tube under reduced pressure

Publications (1)

Publication Number Publication Date
JPH05115464A true JPH05115464A (en) 1993-05-14

Family

ID=17963959

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3307012A Pending JPH05115464A (en) 1991-10-25 1991-10-25 Blood taking tube under reduced pressure

Country Status (1)

Country Link
JP (1) JPH05115464A (en)

Similar Documents

Publication Publication Date Title
EP0193279B1 (en) A vacuum blood-collection tube
Coleman et al. Blood–materials interactions: the minimum interfacial free energy and the optimum polar/apolar ratio hypotheses
US4985026A (en) Blood collecting tube
Iwasaki et al. Reduction of surface‐induced platelet activation on phospholipid polymer
JP2866803B2 (en) Two-way clotting accelerator for blood collection tubes
US5068269A (en) Cellulosic membranes
US5320812A (en) Clot activating polyelectrolyte complex and blood collection assembly containing same
EP0984279A2 (en) Evacuated blood collection tube for rapid blood coagulation
JP2567500B2 (en) Vacuum blood collection tube
JPH05103772A (en) Vacuum blood drawing tube
JPH05115464A (en) Blood taking tube under reduced pressure
US5169543A (en) Serum separation sealant and fine resin particles using the same
Mori et al. Interaction of polystyrene/poly (γ-benzyl l-glutamate) and poly (methyl methacrylate)/poly (γ-benzyl l-glutamate) block copolymers with plasma proteins and platelets
JP3495106B2 (en) Blood component adhesion preventing agent, blood test container and blood component adhesion preventing carrier
CA2495728C (en) Method for the detection of antibodies and/or antigens in a test liquid, particularly for determining the blood group
JP3420855B2 (en) Blood test containers and carriers
JP3206329B2 (en) Blood test container
JP2001305131A (en) Vessel for blood test
CN115308010A (en) Antibody protective agent and blood collection tube
JPH03218736A (en) Vacuum blood taking tube
JPS58195151A (en) Vessel for blood examination
JPH0249099B2 (en)
KR960006652B1 (en) Blood collecting tube
JPH0126503B2 (en)
JP2663898B2 (en) Vacuum blood collection tube